Memorial Sloan-Kettering Cancer Center researchers identified a trio of microRNAs that suppress metastasis, and a group at The Wistar Institute found two miRNAs that promote metastasis. The findings show the utility of miRNAs in cancer prognosis, although companies that market mRNA-based tests question whether miRNAs add any more predictive power.